Follow on Google News News By Tag News By Place Country(s) Industry News
Follow on Google News | Novus Biologicals launches first TMEM97 antibody on the marketNovus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, announce that they have launched the first TMEM97 antibody onto the market.
By: Jhon carlos The Novus Product Development Team is excited to announce the launch of a new antibody target not currently available by any other antibody supplier. The two new antibodies are a human TMEM97 antibody (NBP1-30436) In a recent publication, Bartz F, et al. identified 20 genes, including TMEM97, that are functional regulators of cellular cholesterol homeostasis (Cell Metab. 2009 Jul;10(1):63- TMEM97 and the other 19 genes identified by Bartz F, et al. are promising targets for the study of how cells control cholesterol levels. Along with TMEM97, four other genes were identified as cholesterol regulators based on their distinct transcriptional activation in response to sterol depletion, including C17orf59, ETV5, SYTL2 and VRK3. Novus Biologicals also provides a full line of cholesterol metabolism related antibodies, peptides, lysates and reagents. To find out more about Novus Biologicals and their antibody database,visit their website at http://www.novusbio.com/ End
Account Email Address Disclaimer Report Abuse
|
|